Brief: Corcept Therapeutics Targets Year-End For Catalyst Treatment Data Release
29/04/2024 13:06
April 29 (Reuters) - Corcept Therapeutics Inc CORT.O :
* CORCEPT COMPLETES ENROLLMENT IN PHASE 4 CATALYST TRIAL
* CORCEPT THERAPEUTICS INC - TARGETS YEAR-END FOR CATALYST
TREATMENT DATA RELEASE
Source text for Eikon: ID:nGNX4N6v79
Further company coverage: CORT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Corcept Therapeutics Incorporated
See all newsDrugmaker Corcept seeks to bar ex-judge's views in Teva antitrust case
Live Markets: US earnings forecast jumps further after key reports this week
Live Markets: Who's next for the S&P 500? The clock is ticking
U.S. RESEARCH ROUNDUP-Equinix, Meta, S&P Global
Corcept Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary